- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-IFITM2/3
IFITM2/3 Monoclonal Antibody for FC (Intra), IF
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain
Applications
IF, FC (Intra)
Conjugaison
CoraLite®555 Fluorescent Dye
CloneNo.
2E8D12
N° de cat : CL555-66081
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en IF | cellules U2OS, |
Résultats positifs en cytométrie | cellules HeLa |
Dilution recommandée
Application | Dilution |
---|---|
Immunofluorescence (IF) | IF : 1:50-1:500 |
Flow Cytometry (FC) | FC : 0.40 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
CL555-66081 cible IFITM2/3 dans les applications de IF, FC (Intra) et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | IFITM2/3 Protéine recombinante Ag17863 |
Nom complet | interferon induced transmembrane protein 3 (1-8U) |
Poids moléculaire observé | 15-20 kDa |
Numéro d’acquisition GenBank | BC070243 |
Symbole du gène | IFITM3 |
Identification du gène (NCBI) | 10410 |
Conjugaison | CoraLite®555 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 557 nm / 570nm |
Forme | Liquide |
Méthode de purification | Purification par protéine G |
Tampon de stockage | PBS avec glycérol à 50 %, Proclin300 à 0,05 % et BSA à 0,5 %, pH 7,3. |
Conditions de stockage | Stocker à -20 °C. Éviter toute exposition à la lumière. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
IFITM3, also named as interferon-inducible protein 1-8U, belongs to the CD225 family. It is IFN-induced antiviral protein that mediates cellular innate immunity to at least three major human pathogens, namely influenza A H1N1 virus, West Nile virus (WNV), and dengue virus, by inhibiting the early steps of replication. IFITM3 is identified as interferon-induced cellular proteins that restrict infections by retroviruses and filoviruses and of influenza virus and flaviviruses, respectively. IFITM3, the most potent antiviral IFITM, was found to inhibit an uncharacterized early infectious event after VSV endocytosis, but before primary transcription of its viral genome. IFITM proteins are viral restriction factors that can inhibit infection mediated by the influenza A virus (IAV) hemagglutinin (HA) protein. They differentially restrict the entry of a broad range of enveloped viruses, and modulate cellular tropism independently of viral receptor expression. This antibody recognizes both IFITM2 and IFITM3.
Protocole
Product Specific Protocols | |
---|---|
IF protocol for CL555 IFITM2/3 antibody CL555-66081 | Download protocol |
FC protocol for CL555 IFITM2/3 antibody CL555-66081 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |